Brief: Lineage Cell Therapeutics Announces First Closing Of Up To $66 Million Registered Direct Offering
Nov 21 (Reuters) - Lineage Cell Therapeutics Inc
LCTX.A :
* LINEAGE CELL THERAPEUTICS ANNOUNCES FIRST CLOSING OF UP TO
$66
MILLION REGISTERED DIRECT OFFERING
Source text: ID:nBw58DmQsa
Further company coverage: LCTX.A
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million